- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-310/13: Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 6 June 2013 — Novo Nordisk Pharma GmbH v Corinna Silber
ECLI:EU:UNKNOWN:62013CN0310
62013CN0310
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
7.9.2013
EN
Official Journal of the European Union
C 260/21
(Case C-310/13)
2013/C 260/37
Language of the case: German
Referring court
Parties to the main proceedings
Defendant and appellant on a point of law: Novo Nordisk Pharma GmbH
Claimant and respondent in the appeal on a point of law: Corinna Silber
Question referred
Must Article 13 of Directive 85/374/EEC be interpreted as meaning that, as a ‘special liability system’, the German system of liability for pharmaceutical products is in general not affected by that directive, with the result that the national system of liability for pharmaceutical products may be further developed, or must that provision be interpreted as meaning that no extension is permitted to the situations covered by the liability system for pharmaceutical products existing at the point in time at which the directive was notified (30 July 1985)?
Council Directive 85/374/EEC of 25 July 1985 on the approximation of the laws, regulations and administrative provisions of the Member States concerning liability for defective products (OJ 1985 L 210, p. 29).
* * *